My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Once A $15 Billion IPO Hope, Swedish Fintech...
Alaska Air Invests In Loft Dynamics To Train...
Trump Reveals Vietnam Trade Talks As Nike Sto...
China Restricts Rare Earth Exports To US As P...
Value Shoppers Still Show Up, But Costco's Gr...
Powell Says It's 'Too Soon To Say' On Rates A...
Strong Jobs Report 'On A Day When Good News D...
Temu Parent PDD Stock Tumbles As Trump's New...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy 0.00%
    Materials 0.00%
    Industrial 0.00%
    Finance 0.00%
    Consumer D... 0.00%
    Consumer S... 0.00%
    Informatio... 0.00%
    Telecommun... 0.00%
    Health Car... 0.00%
    Utilities 0.00%
    Oil 0.00%
    Gold 0.00%
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    GUGGENHEIM STRATEGIC OPPORTUNITIES (NYSE: GOF)

    Overview
    current price
    $13.86
    $13.86
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    13.86
    open
    0.00
    volume
    0.00 M
    30d. avg volume.
    1.16 M
    1 day
    0.00 - 0.00
    52 weeks
    13.68 - 16.08
    p/e
    0.00
    beta
    0.5819
    market cap
    2.25 B
    dividend yield
    15.77%
    Industry
    -
    GOF by TradingView
    News and Commentary
    Regeneron Antibody Therapy Showing Promise A coronavirus antibody treatment being tested by Regeneron
    IPO Update: Casper Sleep Invests in the "Sleep Economy" Well-know private mattress maker Casper Sleep filed its S-1 paperwork with the U.S. Securities and Exchange Commission on Friday. The company views itself as a major player in th...
    StockTwits
    StockTwits
    Most Shared
    Meta Is Paying 'Way Above Market Rate' For Reality Labs Developers As Metaverse Losses Mount
    Instacart Rolls Out Personalized Smart Shop Feature With AI Tech
    Market Update: Dow Falls 100 Points on New Auto Tariffs
    Most Popular
    Apple Set For Strong iPhone Upgrade Cycle Driven By AI, Analyst Says
    Donald Trump Sets Reciprocal Tariffs On Key Trade Partners In Historic Policy Shock
    Uber Teams Up With WeRide To Bring Self-Driving Cars To Dubai
    popular tags
    Earnings
    Apple
    Coronavirus
    Amazon
    Coronavirus Impact
    Covid-19
    Tesla
    Google
    Covid19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2025 Passport to Wall Street
    Quotes are at least 20 minutes delayed